AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC

Go back to AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC
Amgen Inc (NASDAQ: AMGN) Delayed: 360.45 --0 (-0%)
Previous Close $360.45    52 Week High $176.85 
Open $360.45    52 Week Low $133.64 
Day High $360.45    P/E 54.28 
Day Low $360.45    EPS $6.64 
Volume 339